Nicolás Ms Gálvez

14PUBLICATIONS
37CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 29, 2024
QuickFit: A High-Throughput RT-qPCR-Based Assay to Quantify Viral Growth and Fitness In Vitro.

Nicolas M S Galvez, Maegan L Sheehan, Allen Z Lin

|Oct 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.

Nicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz

|Sep 12, 2022
From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection.

J A Soto, N M S Galvez, D B Rivera

|Aug 10, 2022
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.

Bárbara M Schultz, Felipe Melo-González, Luisa F Duarte

|Jul 27, 2022
Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial.

Katia Abarca, Carolina Iturriaga, Marcela Urzúa

|May 28, 2022
BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus.

Jorge A Soto, Fabián E Díaz, Angello Retamal-Díaz

Pageof 3

Frequent Collaborators

12 joint publications

Alexis M Kalergis

9 joint publications

Susan M Bueno

7 joint publications

Gaspar A Pacheco

6 joint publications

Pablo A González